Close
Digital Health & Ai Innovation summit 2026
LiGHT26

US Hospital & Provider Trends To Watch Out For This 2024

Healthcare providers across the US have gone on to keep a close eye on rising expenses as countrywide labor shortages, inflation, as well as a dried-up COVID-19 relief funding have all gone on to push the health systemsโ€™ operating margins into the red.

However, in spite of hospital executivesโ€™ best push at cost management, 2024 is not going to bring a reprieve from the razor-thin operating margins when it comes to most systems, warn experts.

As per the senior director at credit agency Fitch Ratings, Kevin Holloran, 2024 is not going to be markedly better and, of course, not the V-shaped recovery one can hope to have. Not-for-profit hospital margins still happen to be below both pre-pandemic levels, but more significantly, they are going to be trending below the operating margin of 3%.

It is well to be noted that analysts happen to be in a split state when it comes to how bleak the picture happens to look for the provider sector. The three major credit agencies of the likes of Moodyโ€™s Investors, Fitch Ratings, and S&P Global Ratings, have gone on to predict an adverse to stable condition for 2024.

But neither the credit agencies nor the sector experts anticipate a complete financial turnaround for the industry this year. The fact is that the provider’s personal outlook is based on their capacity to make sure to pull the right combination of levers that not just lift revenues but at the same time deplete costs, say experts.

Providers to fund outpatient care, move away from expensive service lines

Health systems are going to elevate the investments in ambulatory care centers in 2024, thereby going ahead with the trend that started in the latter half of last year, as the hospitals looked out to grow their geographic footprints at comparatively low costs and at the same time make an appeal to evolving patient preferences.

It is well to be noted that hospitals may go on to be more tempted to invest in 2024 as advancements in technology go on to make additional outpatient processes possible and systems start to witness returns from basic investments, said the experts.

As per healthcare senior analyst with management consultancy RSM US, Danny Schmidt, healthcare happens to be moving to where the patient wants it to be. Making sure to place free-standing sites across convenient locations that are able to embrace emerging technological trends can go on to attract recurring patients and thereby can be less capital-intensive as compared to traditional large hospital brick-and-mortar settings.

It is worth noting that major health systems across the US have gone on to announce plans to expand. In 2023, HCA went on to place a multi-billion-dollar bet when it came to emergency services, including the acquisition of free-standing care sites. In addition to this, Ascension announced plans to move towards outpatient services.

Apparently, health systems may go on to opt to buy existing facilities, such as HCA, or even go ahead and build facilities from the ground up, completely depending on their strategy, said Holloran from Fitch. Notably, in November 2023, nonprofit Kaiser Permanente made a land purchase adjacent to its San Jose, California, facilities for a possible outpatient expansion.

On the other hand, struggling hospitals may go on to make the stressful decision to either shutter or lessen the underperforming service lines in 2024, opined Holloran.

Closures when it comes to maternity services, inpatient rehabilitation services, or behavioral units are most likely to take place at smaller hospitals or even rural facilities, experts remarked.

Across the country, rural hospitals have already started to shutter more expensive service lines so as to keep facility doors open. Importantly, hospitals that shut services have gone on to cite dearth of financial reserves to staff service lines having low volumes.

Although hospitals would like to go ahead and keep the service lines open, economic conditions as well as fee-based reimbursement models may enforce more hospitals to follow the same path this year. It is well to be noted that closures can go on to prove disruptive for patient care, especially for patients of color, thereby forcing some patients to drive for hours to another facility, as per research from Harvard T.H. Chan School of Public Healthโ€™s Alecia McGregor, who happens to be an assistant professor of health policy and politics.

Patients may as well have to depend on non-traditional venues like free-standing emergency centers when it comes to services, as per the Center for Health Quality and Payment Reformโ€™s spokesperson.

The fact is, hospitals will insource where it matters, but outsource where they can

Hospital executives took into account the earnings call in 2024, which elevates labor expenses, which is the new normal post-pandemic.

However, while the executives said they are going to pay a premium in order to attract nurses as well as physicians moving forward, in all likelihood, hospitals are not ready to give up on initiatives that are aimed at controlling labor expenditures.

This year, the health systems are going to further invest when it comes to grow-your-own nursing programs, in which the systems partner with or otherwise acquire a nursing college so as to develop a direct recruitment pipeline, as per the experts.

It is well to be noted that executives at HCA, Tenet, as well as CHS said nursing programs happened to be instrumental when it came to helping to surge recruitments in 2023.

Importantly, nursing program partnerships are most likely going to be the norm throughout the industry this year as hospitals go on to further invest in grow-your-own nursing programs. But the health systems are going to be less inclined when it comes to spending on their IT as well as administrative departments.

Notably, in 2023, one witnessed a wave of IT as well as administrative layoffs, such as at Kaiser Permanente and Mass General Brigham, where providers either cut, automated, or even outsourced roles.

As per experts, Multi-State Systems specifically will go ahead with the consolidation of administrative and tech functions in a want for efficiency.

According to Wiggins, one can expect a surge in outsourcing to third parties, specifically for IT and revenue cycle services, in 2024. Possible candidates for offshoring have highly repeatable tasks like medical billing as well as coding and transcription services, in addition to telehealth support services. However, in all likelihood, health systems may have their hands tied by union contracts when they look to lay off the workforce. This fall, around 75,000 Kaiser Permanente workers went on to negotiate outsourcing protections in their employment agreements. Over a period of time, when Kaiser went on to announce a decrease in the workforce, no union members were impacted.

Consolidation goes on despite pushback from regulators and physicians

It is worth noting that providers will continue to look into consolidation as economic pressures go on put light on the functional upsides of combined management. But experts disagree on the avenues health systems are most likely to pursue.

Because of the fact that the healthcare mergers may go on to face heightened scrutiny in 2024 post the Federal Trade Commission and Department of Justice made an announcement of the new guidelines for merger and acquisition oversight in December, some experts happen to be betting that health systems will go ahead with roll-ups, wherein they would acquire market share in a series of transactions.

Health systems may go on partner with non-traditional partners such as tech giants, retailers, or even telecom companies as the sector goes on to experience more pressure towards convergence, says Deloitte Center for Health Solutionsโ€™ senior manager, Wendy Gerhardt.

Apparently, large system-to-system mergers within the non-contiguous markets will go ahead. But they are likely to experience closing delays because of the antitrust scrutiny, as per the sector lead of the U.S. not-for-profit healthcare group, S&P Global Ratings, Suzie Desai.

Merger activity decreased during the pandemic, but larger mergers are anticipated post-pandemic, as per Kaufman Hall.

Not all physicians are going to be happy with consolidation. Almost 60% of physicians working with hospitals as well as other corporations expressed in a survey conducted by the Physicians Advocacy Institute in 2023 that non-physician ownership goes on to harm quality of care. The physicians pointed to a reduced time with patients, and 44% of the respondents remarked that they would look to join a trade union if one happened to be available.

August from Cornell said that he has fielded inbound interest from physicians who are looking for guidance on how to plan or leverage the professional affiliation memberships so as to affect the transition as healthcare consolidation goes on.

He added that he is not sure he has ever seen anything so radical take place in an industry as rapidly as it has within the doctor community. However, he also thinks that they are at a tipping point where conversations are fast, furious, and, at the same time, almost identical all across the country.

It is well to be noted that consolidation may also go on to put pressure on existing health unions, as per August.

Making Righteous Use of Health Data For Anticipated Cures

The kind of data that healthcare brings about with every passing second happens to be almost incomprehensible. It is well to be noted that by 2020, it was anticipated that the healthcare sector across the globe could go on to generate 2.3 zettabytes of data.

It is worth noting that we happen to be in the middle of a global digital health revolution. The capacity to harness this huge amount of health data goes on to promise better as well as more effective cures due to effective treatments, while at the same time making sure to free up resources that are scant which are already due to stretched health systems. The fact is that digital can very well turn out to be the key lever when it comes to sustainable development goals target 3.8 of attaining Universal Health Coverage- UHC, which is one of the three health topics that happen to be covered at a UN High-Level meeting at the UNGC this year.

When we talk of the evolving global health spectrum, the compulsion for effective as well as value-driven systems of healthcare is the highest. The rising intricacy, dearth of standardization, as well as coordination, which are teamed with some huge potential of data on health that is untapped, highlight the requirement for transformative change. Apparently, leading countries that are a part of the G20 and G7 acknowledge the significance of health data, stressing the international cooperation when it comes to digital health as well as data usage. Notably, Japanโ€™s partnership with the EU goes on to serve as a benchmark when it comes to cross-border health data flows, syncing with standards of international data protection.

In spite of the unmatched growth in the data pertaining to health, an astounding 97% of the same is not of any use, thereby reflecting upon a distinct opportunity to elevate the performance of the health systems. The point lies in creating linkages that are sustained, transforming huge amount of information thatโ€™s unstructured into actionable insights, and thereby enhancing the data flow so as to support maximum care as well as interventions that go beyond the clinic walls.

Major issues which relate to health data access

The COVID-19 pandemic has indeed gone on to teach us various digital lessons. In an international crisis, there should be the capacity to quickly collect as well as gauge huge amounts of health data in order to manage the spread of viruses. Elevated telehealth usage, contact tracing, tracking of the outbreak, virus testing, as well as medical research, all happen to generate more health data than most organizations anticipated or were even prepared for.

It is worth noting that there were three critical themes that went on to emerge- the magnitude of data; concerns related to data privacy; and the requirement when it comes to interoperability. However, it also remains crystal clear that these three factors can at times go on to conflict with each other, and therefore ensuring to find the exact balance is imperative.

With more than 2.3 zettabytes of global health data, access to the data thatโ€™s must and right is very significant when it comes to innovations like AI. That said, the siloed as well as highly regulated nature of health data goes on to possess great challenges.

Enhancing the capture of data, its sharing and usage

A recent analysis done by the World Economic Forum went on to find that a typical hospital goes on to produce 50 petabytes every year. This mass of data happens to have notes pertaining to clinical trials, laboratory tests, readings of sensors, medical images, genomics, as well as data on functions and finance. Still, 97% of all global data that gets produced by hospitals annually is unused. It is well to be noted that data happens to be the lifeblood of AI-powered research.

Notably, wearable tech, smartphones, as well as applications all go on to contribute valuable health data thatโ€™s user-generated. The fact is that such user-generated data can go on to assist the existing clinical data, thereby enabling individuals to track chronic conditions even when at home and thereby enhance the outcomes by way of offering early data access that goes on to pinpoint the exact problem right before it goes on to become serious. However, this also means ensuring consent, security, accountability, and transparency happen to be hard-wired into any system.

If the issues when it comes to the volume of data along with privacy can be overcome, then the third challenge comes into picture. Significantly, interoperability needs the custodians of the data so as to share precise and timely data in a very safeguarded as well as controlled manner by way of using a common language, while the authorized users of such kind of information, like the providers, should have the capacity to pull or, in certain cases, push data from numerous sources, integrate as well as augment that data, and then expose it in the form of aggregated information to a much wider audience. The challenge here is a lack of common standards when it comes to connected health services.

The question is, how should we go on to create a fair and balanced system that goes on to realize the game-changing potential of this humongous volume of data so as to push patient outcomes that are better?

It is well to be noted that coming up with this digital health ecosystem happens to be at the top of mind for global partners, and the process of bridging the world that is digitally divided pertaining to health systems has robust momentum, with many global bodies such as the World Health Organization- WHO, PATH, and Transform Health, among several others, defining the path and at the same time making huge strides. But there still happens to be a crucial requirement to speed up as well as amplify the effect when it comes to these efforts. Finding the solutions that are right will only take place by bringing together players from across all the verticals as well as geographies. This therefore means uniting public, private, as well as civil organizations throughout the healthcare gamut and even those from insurance, technology, life sciences, retail and consumer sectors, finance, and many more. This is what the forum goes on to do.

Developing on its longstanding commitment when it comes to systems transformation, the Forum happens to be now spearheading an initiative thatโ€™s completely focused on transforming healthcare by way of digital health, having an approach thatโ€™s completely value-driven via an initiative known as Digital Healthcare Transformation, which happens to be a natural progression from its basic work when it comes to value-based healthcare. This goes on to get digital transformation as well as high-value care together with the objective of enhancing patient outcomes.

Notably, the value driven data along with digital healthcare can indeed go on to make a great difference when it comes to delivering high-value care by way of using data as well as analytics at a level thatโ€™s entirely different.

At the World Economic Forum Annual Meeting this year, the world leaders will unite to champion a global collaboration for healthcare transformation thatโ€™s responsible. A dedicated strategic session looks to center the global sectorโ€™s voice within key international forums such as the G20 and G7, as well as the EU agenda.

AI Infra To – 2024 Healthcare Tech Trends

Digital health as well as health technology adoption went on to advance quite rapidly in the wake of COVID-19, as investor dollars flooded into the landscape and providers went on to quickly pickup telehealth capacities.

However, the funding has gone on to slow down quite predominantly from its pandemic boom in 2021, with some companies shutting their doors in 2023. Nevertheless, interest in emerging technologies happens to be quite high this year, especially as AI promises to make sure to streamline operations and also lessen administrative burdens in case of clinicians.

It is well to be noted that as organizations go on to digitize, cybersecurity happens to remain a significant challenge, with breaches in healthcare data exposing umpteen patientsโ€™ sensitive personal and health info.

This year may go on to prove a development period when it comes to the health technology sector, as said by experts. Providers as well as payers will work in order to integrate digital tools all across their organizations, and industry watchers may as well see efficacy and outcomes data after years of investment in digital health.

2024 can also include more evolution of the present levels of technology instead of earth-shattering new inventions, remarks the lead analyst in healthcare IT at market intelligence company CB Insights, Alex Lennox-Miller.

The speed at which change is taking place with technology in healthcare across the last couple of years has been really rapid, Alex opines. If one can go on to maintain that kind of pace even without something that is completely game-changing as well as revolutionary, that would indeed be a huge win when it comes to the healthcare industry as a whole.

Mergers & acquisitions may pick up as digital health funding goes on to normalize

Investment when it comes to digital health companies has gone on to reach year-low levels in 2023, following a dip that started in mid-2022. Higher interest rates, which happened to limit venture capitalโ€™s capacity in order to raise funds, lower valuations, and a frozen IPO market went on to further decrease the available cash in the case of startups.

However, this decline is not a complete collapse when it comes to this industry. Instead, it goes on to reflect a normalization after the investment explosion that took place in 2021, say experts. Digital health funding levels in 2024 are all set to look very familiar to 2023 and may as well begin to increase, especially in the latter half of 2024, although the floodgates are not just opened entirely.

It is well to be noted that even consolidation may go on to pick up in 2024, a trend that sector enthusiasts have been eyeing for months since the funding ticked down and even potentially pushed startups when it comes to dealmaking. Digital therapeutics, mental health providers, and weight loss companies could be attractive targets of acquisitions, experts opined.

High-quality products that go on to solve narrow healthcare problems happen to be potentially the best opportunities when it comes to consolidation, opines the CEO of the Digital Medicine Society, Jennifer Goldsack.

Buyers when it comes to digital health products are indeed tired in terms of managing plenty of point solutions; hence, the quality offerings that could be brought as more of an integrated tool are indeed valuable, specifically in the case of healthcare giants such as CVS Health or startups that can very well raise heavy Series D rounds. Apparently, this can also go on to force the cream to rise.

As per Goldsack, what they are really looking forward to seeing is consolidation, picking out the best practices, usage when it comes to the very best in tech, and the best teams being together in order to really offer complete solutions to the issues in healthcare instead of individual tools.

Now that some digital health startups that have been funded during the height of the investment boom are functional for several years, the industry can see data on how efficient these solutions can be when it comes to improving access as well as quality of care, said founder of venture capital firm Vive Collective, Cheryl Cheng.

She added that this is where one can see a little bit of that kind of separation between wheat and chaff with regards to the companies that have built really strong clinical models along with good unit economics and can scale, as opposed to the ones that may have been still drafting off of pandemic tailwinds.

Building the AI infrastructure in healthcare

The buzz on the potential for AI in healthcare touched a fever pitch in 2023, specifically when it came to generative AI technology, which can very well create new content like text or images. Tech giants such as Google, Oracle, Microsoft, and Amazon went on to announce new products in 2023 that were aimed at tackling functional tasks and, at the same time, decreasing administrative burdens.

However, all this is still early with regards to generative AI. The sector is still in the exploration phase in terms of how it could be best made use of, said partner at digital health venture capital firm GSR Ventures, Sunny Kumar.

If one looks at the mobile phone as a platform, Kumar opines that no one would have predicted in 2009, when the iPhone was launched, that the sectors the iPhone would disrupt most would be the taxi industry with apps such as Uber or even the mapping industry, for that matter, with things such as Google Maps.

The infrastructure when it comes to AI needs to be developed, including tools that will be efficiently integrated within the healthcare system, how to set as well as follow appropriate safety along with compliance standards, and how buyers of such products will go on to learn what data they happened to be trained on.

In 2024, there may as well be less hype along with money flowing into the space as developers nourish the seeds they planted in 2023, remarked Cheng from Vive.

It is well to be noted that transparency will become exceedingly significant this year, specifically in the case of clinical decision support tools or even algorithms that go on to assist with claim appraisals, said Lennox-Miller from CB Insights.

Lawmakers went on to hear the testimony last year in the case of algorithms used by insurers so as to predict how much care patients may go on to need, which advocates argued pushed the coverage denials and got patients to self-pay or manage the appeals process. The likes of Humana, Cigna, as well as UnitedHealth were sued in 2023 over their usage of algorithms to process claims.

Lennox-Miller added that, for lack of a better way to put it, the transparency needs to be more transparent, and if one is showing that the algorithm works, and if it is another math equation or an extremely complex set of documents, it really does not help at all.

Regulators eye cybersecurity benchmarks

Healthcare organizations will need to be serious when it comes to cybersecurity this year, and they may as well face some growing regulatory pressure in order to tamp down the breaches in data, said experts.

It is worth noting that breaches when it comes to healthcare organizations have gone on to become very common in the past five years. The HHSโ€™ Office for Civil Rights discovered a 93% surge in large breaches that were reported to the agency in just a matter of 5 years from 2018 to 2022 and a 278% spike when it came to breaches that involved ransomware during the same period.

Partner at law firm Morgan Lewis, Amy Magnano, opines that cyberattacks initially went on to aim larger healthcare systems, but smaller providers as well as business associates now happen to be the targets, with attackers becoming more sophisticated too, by way of using AI and machine learning tools so as to hone their strikes, which include crafting compelling phishing emails, all the more.

Apparently, more states may very well go on to create their very own healthcare cybersecurity regulations in 2024, Lewis said. To name a few, New York has already proposed its own rules for hospitals in November 2023, which look to safeguard facilities and at the same time keep them functioning even when cyberattacks take place, with funds allocated in the stateโ€™s budget so as to help hospitals elevate their technology systems.

States such as California, Washington, or even others that already have more robust medical record requirements may as well be interested in regulation, Magnano remarked, but the providers will likely consider improved infrastructure, funding, or even guidance as compared to a regulatory approach thatโ€™s fragmented.

The HHS has gone on to signal interest when it comes to boosting cybersecurity needs for hospitals by way of Medicare and Medicaid, thereby coming up with a concept paper in December 2023 that outlined a strategy in order to receive new authority as well as funding.

Although the intent happens to be good, numerous hospitals have already started operating on slim margins, specifically rural facilities that require to stay operating in order to preserve access to care within the communities they serve, said Goldsack from DiMEโ€™s. It is well to be noted that the risk calculus may have already been edited for providers, as they face penalties and damages from lawsuits due to data breaches.

Apparently, to make matters worse, cybersecurity experts are not as easy to find, said partner and U.S. healthcare leader at Deloitte, Tina Wheeler. Some health systems have gone on to move to outsource their cybersecurity teams, specifically if they happen to be small and cannot afford expansive staff.

Whatever the thing is, healthcare organizations will need to be very sharp when it comes to upskilling their entire workforce in cybersecurity practices since only one weak link can lead to a data breach.

Immense Promise Reflects In Vison of Google Cloud For 2024

Google Cloud on January 9 went on to announce its bold thought for healthcare for the year ahead.

It is without any doubt that the company has gone on to make a name for itself in the healthcare gamut in the last few years. Significantly, due to the recent buzz that has been centered around AI, Google Cloud has gone on to be at the forefront of innovation.

It is well to be noted that 2023 happened to be one of the best years for Google Cloud, as the organization went on to deploy yearsโ€™ worth of investments as well as research by way of a variety of varied products. Google Cloud has been pretty hefty on research in healthcare, considering that it happens to be a very vast field and that there is no dearth of opportunities regardless of the geography. For healthcare, amidst the most notable products happened to be Vertex AI Search as well as the companyโ€™s latest release, MedLM, which is a family of foundation models specially built with healthcare sector use cases in consideration.

Vertex AI Search happened to be made a splash in 2023 as one of the first services within the industry that could go on to empower organizations to make optimal use of the power of generative AI search in terms of healthcare applications. In particular, the technology goes on to give the users the capacity to search as well as glean insights from a wide spectrum of clinically effective sources, like clinical notes, electronic health records, as well as other documents. Significant customers that range from Hackensack Meridian Health as well as Highmark Health to Meditech and the Mayo Clinic happen to be already making use of this technology.

MedLM happened to be yet another groundbreaking release by the company last year, building on the previous edits of Med-PaLM and years of deep dive within this space. The idea behind MedLM is to empower firms with the power of AI throughout a wide spectrum of applications as well as tasks. For example, Augmedix, which goes on to provide ground-breaking ambient dictation tech for clinicians. Augmedixโ€™s core tech makes use of Google Cloudโ€™s MedLM on Vertex AI, apart from natural language processing, so as to translate data into drafts of medical notes. Yet another key example happens to be the life sciences space, where organizations such as BenchSci are making use of MedLM so as to make their drug research, discovery, and development processes more trustworthy and exact.

All this was in 2023

The Global Director of Healthcare Strategy & Solutions, Google Cloud, Aashima Gupta, goes on to thoughtfully explain that 2023 happened to be just the start of this new era, and 2024 is going to see a phenomenal progress as the technology goes on to shift from experimentation and trials to actual, real-time world use-cases so as to help organizations get better insights through their data, reduce the administrative burdens for clinicians, as well as palpably help enterprises be more successful as well as efficient.

She goes on to tactfully explains the pathway ahead which predominantly comprises of three major categories: Short-term optimization, which goes on to refer to leveraging AI so as to help ease the urgent administrative burdens as well as cognitive burdens which happened to be faced by health systems as well as practitioners; Long-term transformation, which is all about using the power of this new tech so as to create more effective as well as efficient clinical workflows, get huge insights from existing data and help interoperability throughout data sources; and conclusively, profound learning, which relate to the fact that the overall ecosystem such as Google, healthcare organizations as well as policymakers, will go on to learn how to actually team AI with the intricacies and nuances of care delivery as well as healthcare outcomes.

Gupta so poignantly remarks that finally, this by and large, a cutting-edge tech is going to push forward a new comprehension when it comes to both health as well as healthcare.

Nonetheless, although the wider outlook when it comes to this technology happens to be optimistic, the work does not look easy by any means. The fact is that the level of hard work, commitment, as well as investment needed to have breakthroughs in this field is indeed immense. Apart from this, the competition to invent is indeed profound. Technology companies throughout the spectrum happen to be swiftly speeding up their endeavours to have a major share of the pie. Let us look at the example of Microsoft, which has gone on to rapidly push up its offerings when it comes to the healthcare artificial intelligence spectrum recently, specifically due to the release of Azure Health Bot. Just like what Microsoft did, even Amazon has gone on to invest pretty heavily in order to empower organizations by means of deploying healthcare analytics as well as machine learning tools.

Besides the fierce competition when it comes to the software and platform side, hardware also happens to be on the top of mind for these companies, as these intricate platforms as well as services go on to require immensely high computing power. It is well to be noted that NVIDIA went on to witness an exponential growth in 2023 for this very reason, given the fact that its industry-leading GPUs that have gone on to show an unmatched resilience and promise. There happen to be certain other contenders, like AMD as well as even Google, due to its efforts with Tensor, which are indeed making valiant strides within this landscape.

There is no doubt at all that 2024 is indeed seen as one of the most humongous years when it comes to this technology and even for the healthcare industry in general. Within this arena, the road ahead for Google happens to be bold, ambitious, as well as very promising, given the fact that it has put years of research, funding, as well as resources to making sure that these efforts go on to find their true place.

MedTech Company KARL STORZ Acquires British AI Specialist Innersight Labs

The family-owned MedTech company KARL STORZ announces the acquisition of the innovative software manufacturer Innersight Labs Ltd. (ISL) headquartered in London. In addition to state-of-the-art endoscopes, high-end medical devices, and integrated solutions for the operating room, KARL STORZ is also continuing to expand in innovative software solutions. Its large customer base, including top-class physicians worldwide, can now look forward to 3D models created from medical scans, making surgery considerably easier and even more successful. The know-how gained with the acquisition in the field of artificial intelligence (AI) will greatly enhance KARL STORZ’s portfolio. The parties have agreed not to disclose the purchase price.

Innersight Labs drives AI solutions for healthcare

ISL is a British company founded in 2015 by Oxford graduates Lorenz Berger and Eoin Hyde, and they were joined shortly thereafter by Matt Gibb, another former Oxford PhD student. ISL developed Innersight3D, a software-only product that allows surgeons to create a patient-specific 3D model from a medical CT or MRI scan. ISL labels received scans according to the different tissue types and creates an interactive 3D model. The three-dimensional representation can then be accessed and interacted with via a web link sent to the physician. Because of the more accurate preoperative assessment, benefits include for example reducing operation time and the risk of surgical complications. Compared to competing products, ISL’s AI-based algorithm can significantly reduce manual effort, reducing cost per model and time to deployment. The company currently employs eight people and also operates an office in India. As part of the globally active KARL STORZ Group, the next steps are to focus on commercial scaling and joint technology development.

Thriving innovation is part of the KARL STORZ DNA

KARL STORZ’s success story originally began in 1945 with innovations in the ENT (ear, nose and throat) sector. The founder Karl Storz had a clear vision to empower minimally invasive surgery and revolutionize the treatment of patients worldwide. In the meantime, the 8,800 employees spanning the firm set the standard for many smart products in the healthcare sector. โ€œWe want to continue pioneering MedTech, particularly in the areas of software and robotics. The research background that ISL brings to the table therefore fits ideally with our vision, mission, and strategic goals. We warmly welcome them to the KARL STORZ family,โ€ said Thorsten Molitor, Executive Vice President at KARL STORZ. The ISL team also has in-depth knowledge of soft tissue deformation and mechanics, computational physics, image processing and machine learning, as well as experience in cloud software development.

KARL STORZ and Innersight Labs combine forces

The acquisition of ISL adds an AI product to KARL STORZ’s existing portfolio. It is a next step on their journey to push AI in laparoscopic and robotic imaging solutions in the healthcare industry. KARL STORZ wants to incorporate the extensive possibilities of AI into the development of cutting-edge medical technology at an early stage and thus bring the best instruments for patients with the highest safety standards to the market.

Close cooperation with KARL STORZ`s robotics entity

KARL STORZ VentureOne, a KARL STORZ subsidiary with a focus on robotics based in Singapore and Munich, is also eagerly anticipating close cooperation with ISL. “The development of our robotic products will benefit enormously from ISL’s knowledge with regard to the use of AI. We are therefore very much looking forward to the cooperation and to further growing together in this area,” said Stephan Abele, Managing Director of KARL STORZ VentureOne.

ShiftMed Launches ShiftAdvisor, an AI-Powered Personalized Scheduling Solution for Nurses

New platform feature enables healthcare professionals to utilize customized scheduling tools tailored to their past shift data and preferences

McLean, Va. โ€“ January 9, 2023 – ShiftMed, the leader in on-demand workforce technology, announces today the launch of ShiftAdvisor, a new AI-powered feature set to transform nurse scheduling and elevate the staffing efficiency of healthcare facilities. This solution is designed to benefit both healthcare professionals (HCPs) and facilities by optimizing shift scheduling, ensuring providers find the best shifts with minimal cancellation risks, and simultaneously enabling facilities to achieve optimal staffing levels.

Healthcare professionals who have worked at least four shifts through the app will now receive personalized shift recommendations tailored to their day, time, pay, and location preferences.

ShiftAdvisor introduces a streamlined approach to shift selection that leverages AI algorithms to align seamlessly with HCPsโ€™ unique skills and financial goals, maximizing their earning potential. It offers a personalized shift recommendation system that serves as both a time-saving measure and a strategic tool for providers to optimize their work schedules.

By receiving AI-powered suggestions aligned with their unique preferences, HCPs can make informed decisions, contributing to a more satisfying and financially rewarding experience. This emphasis on personalization empowers providers within the app, making it easier than ever to have full control over their schedules.

In parallel, healthcare facilities benefit from an intelligent system that minimizes the risk of last-minute cancellations, resulting in enhanced operational efficiency and cost savings. This dual-benefit approach reaffirms ShiftMed’s commitment to providing user-centric solutions, ensuring a streamlined scheduling experience for both healthcare professionals and facilities on the app.

ShiftMed’s dedication to innovation in workforce management is evident through this latest development, showcasing its abilities to provide state-of-the-art solutions for both healthcare professionals and facilities. This is further underscored by the company’s impressive growth and strategic partnerships, including collaborations with renowned institutions such as SSM Health, Hennepin Healthcare, and Presbyterian Healthcare Services.

“The customized shift suggestions in ShiftAdvisor is a targeted tool designed to meet the specific needs of our HCPs and enhance their experience on the ShiftMed platform,” explained Todd Walrath, CEO of ShiftMed. “Our commitment to improving the state of the healthcare workforce is evident in this new feature, which not only empowers users but also delivers added benefits to our facility partners. ShiftAdvisor exemplifies our dedication to creating a platform that caters comprehensively to healthcare professionals’ diverse and evolving needs.โ€

For more information about ShiftAdvisor, please visit https://www.shiftmed.com.

What You Must Know About Mesothelioma and Its Health Implications

Mesothelioma is a rare and aggressive form of cancer that affects the thin lining of tissue covering many internal organs, known as the mesothelium. It is primarily caused by exposure to asbestos, a naturally occurring mineral commonly used in construction materials until its ban in the late 1970s. Despite being considered one of the deadliest forms of cancer, many people are still unaware of what mesothelioma is and the serious health implications it can have.

In this blog post, we will delve into the basics of mesothelioma, its causes, symptoms, diagnosis, treatment options,ย asbestos copmensation claims, and the importance of early detection for better outcomes. So letโ€™s get started!

Understanding Mesothelioma

Mesothelioma is a type of cancer that affects the lining of organs such as the lungs, heart, and abdomen. It is caused by exposure to asbestos, which has been widely used in construction materials for many years. Asbestos fibers can be easily inhaled or ingested and can remain in the body for decades before causing symptoms.

There are three main types of mesothelioma: pleural (affects the lungs), peritoneal (affects the abdomen), and pericardial (affects the heart). Each type has its own unique set of symptoms and treatment options.

Early detection is crucial for effective treatment, as mesothelioma is often diagnosed in its advanced stages when it becomes more difficult to treat. It is important to be aware of the risk factors and symptoms of mesothelioma for early detection and better outcomes.

Causes of Mesothelioma

As mentioned earlier, exposure to asbestos is the primary cause of mesothelioma. Asbestos was widely used in various industries, such as construction, shipbuilding, and automobile manufacturing, due to its heat-resistant and insulating properties.

When asbestos fibers are inhaled or ingested, they can become lodged in the lining of organs and cause damage over time. It is estimated that around 80% of mesothelioma cases are directly linked to occupational exposure to asbestos.

If you are suffering from mesothelioma and have a history of exposure to asbestos, it is important to seek legal assistance as you may be entitled to compensation. For instance, Syracuse Asbestos Exposure lawyers can help you understand your legal rights and get the compensation you deserve. Other potential causes of mesothelioma may include genetic predisposition, radiation exposure, and viral infections, but these are still being researched.

Symptoms of Mesothelioma

Symptoms of mesothelioma can vary depending on the type and stage of the cancer. In the early stages, most people may not experience any symptoms or may confuse them with common respiratory illnesses. As the disease progresses, symptoms may become more severe and include shortness of breath, chest pain, persistent coughing, fatigue, weight loss, abdominal pain and swelling, bowel changes, and night sweats.

It is important to note that mesothelioma symptoms often take 20-50 years to develop, which can delay diagnosis and treatment. Therefore, it is crucial to be aware of any potential risk factors and seek medical attention if you experience any persistent symptoms.

Diagnosis and Treatment Options

Diagnosing mesothelioma involves a thorough evaluation of a person’s medical history, physical examination, imaging tests (X-rays, CT scans, MRI), and tissue biopsy. A biopsy is the only definitive way to confirm a mesothelioma diagnosis.

The treatment options for mesothelioma depend on the type and stage of cancer, as well as a person’s overall health. They may include surgery, chemotherapy, radiation therapy, targeted therapy, and immunotherapy. In some cases, a combination of these treatments may be recommended.

Early detection is vital for successful treatment and improved outcomes. Treatment in the early stages of mesothelioma can potentially lead to long-term remission, but unfortunately, most cases are diagnosed in later stages when treatment options are more limited.

Coping with Mesothelioma

A diagnosis of mesothelioma can be overwhelming and life-changing, not only for the person affected but also for their loved ones. Coping with this disease requires a multidisciplinary approach involving medical professionals, emotional support, and practical assistance.

Support groups and counseling can provide valuable emotional support for both patients and caregivers. Seeking financial assistance and legal advice may also be necessary for managing medical expenses and exploring legal options for compensation.

It is essential to prioritize self-care, maintain a healthy lifestyle, and make the most out of each day. With advances in treatment and ongoing research, there is hope for better outcomes and improved quality of life for those affected by mesothelioma.

Mesothelioma is a rare but deadly form of cancer caused by exposure to asbestos. It can affect different organs and has a long latency period, making early detection challenging. Understanding the risk factors and symptoms of mesothelioma is crucial for timely diagnosis and treatment. Treatment options are available, but they depend on the type and stage of cancer. Coping with mesothelioma requires a comprehensive approach involving medical care, emotional support, and practical assistance. With ongoing research and advancements in treatment, there is hope for better outcomes and improved quality of life for those affected by this disease.

US & UK All Set To Shake-Up Medical Devices Market In 2024

Prominent regulatory changes throughout the numerous medical fields are coming in 2024, with pharma and medical device companies urged to be on with a year of legal edits.

Right from the UKโ€™s reworking of the Voluntary Scheme for Branded Medicines- VPAS as well as delayed plans in order to introduce a new medical device validation scheme, to the USโ€™s attempt to regulate products that make use of AI, 2024 is all set to be a busy year when it comes to healthcare regulators.

US: Regulating Laboratory-Developed Tests

Chief among US legal shifts set to come into effect in 2024 that have gone on to raise concern is the Food and Drug Administrationโ€™s- FDAโ€™s plan so as to regulate laboratory-developed tests- LDTs as medical devices, a strategy that has gone on to see pushback from numerous companies that suggest that the move is indeed unwanted.

The proposed rule looks to amend the FDAโ€™s regulations in order to make explicit that in vitro diagnostic products- IVDs happen to be devices under the Federal Food, Drug, and Cosmetic Act. This is when in case of the manufacturer of the IVD happens to be a laboratory.

The move has gone on to receive criticism from groups like the Utah University-based ARUP Laboratories, which argues that the research, which is published in the American Journal of Clinical Pathology, goes on to detail that 93.9% of tests ordered in 2021 happened to be tests that were cleared, given a nod, and also authorized by the FDA.

Former FDA adviser and partner for Foley & Lardner, the legal company, David Rosen, summarized how the shift in regulation can go on to cause uncertainty.

According to Rosen, the LDTs have been on the market for some time now. He thinks what the FDA happens to be saying is that they are looking to have more data so that they can go on to have confidence in the reliability of such tests and the capacity of practitioners in order to rely on the results that happen to come from these tests.

He added that they are going to have to staff up so as to be able to do it because it is going to be a challenge; there happens to be a significant number of them out there, and whether or not organizations are just coming into the market so as to be able to do this and get the tests cleared via the FDA and how quickly it is going to be done is going to remain an issue.

It is well to be noted that the FDAโ€™s rationale when it comes to this decision is that the concerned patients can go on to initiate unnecessary treatment or delay or even forego proper treatment, which is based on inaccurate test results, a thing that they worry can go on to cause harm. The FDA has gone on to say that since the initial rules with regards to the regulation of LDTs were brought to the fore with the Medical Device Amendments of 1976 ruling, such tests have become rapidly more complex, varied, and, at the same time, able to be run with much greater capacities than ever before.

Partner for US law firm Sidley, Torrey Cope, has gone on to detail as to how he felt about the announcement amongst life science firms, which was kind of mixed, with some firms embracing the announcement better than others.

Cope went on to say that either way he thinks it will go on to have a big impact on pharma companies as they have increasingly had to deal with companion diagnostics so as to get approval for numerous products, and in some cases, a prominent amount of the testing usage in the real world happens to be a laboratory-developed test, and that is an issue they had always wanted to navigate.

If their labelling says that they have to be making use of an FDA-approved test and they know physicians are using a non-approved lab-developed test, how would they navigate that? Certainly, if in case the legal landscape gets altered, that will go on to completely change how they plan for that challenge going forward.

March-in rights

Beyond the FDA, the Biden Administration does have plans to allow agencies to make use of march-in rights to regulatory changes across the US and UK so as to watch in 2024 patents of government-funded drugs if it goes on to feel that pharma firms have gone on to price them too high. This would be done by making sure to take advantage of a clause in the 1980 Bayh-Dole Act that enables the government to grant production rights to government-funded patents to third parties if the product does not become accessible to the public.

But in making the announcement, the White House has gone on to urge that the usage of march-in rights will be particularly fact-dependent and will be based on the totality of all the circumstances.

David Rosen goes on to predict that this will likely lead to substantive challenges and debate, legal as well as otherwise, over whether the government truly possesses the right to seize patents and that it happens to be having the capacity to stifle the USโ€™ research and development landscape, arguing that the government cannot set drug prices.

Rosen went on to say that he thinks that there is going to be immense controversy and litigation over this and that he wants the National Institute of Health- NIH to participate due to the nature of the cutting-edge research it happens to be doing and to have the government gauge what is going on, but to enable the government to come in and seize those patents, they will go on to have to strike a balance.

It is indeed very hard to analyze the cost-effectiveness of the therapy if it costs a lot of money but goes on to treat the disease, which is better for the healthcare system than not going ahead with the therapy at all. If the government goes on to march in and seize patent rights, that is very likely to have an adverse effect on continued drug development by way of using NIH funding.

Following this announcement that was made by the Biden administration went on to reveal further initiatives that include a plan to require some drug companies to go ahead with price negotiations for some drugs in order to stay in line with inflation, thereby underscoring 48 drugs in the Medicare program that have experienced price surges surpassing inflation in Q4 2023.

UK: Medical Devices Shake Up as well as Voluntary Medicines Pushback

In the UK, the medical device market is all set to see a shake-up as the country goes on to prepare to replace the already set-up European Union CE marking with its own UKCA marking, which is intended as the national equivalent to the certification following the nationโ€™s exit from the EU.

It is well to be noted that initially, device manufacturers whose devices had a CE mark would have needed to change over to the UKCA system by June 2023; however, this was later delayed by the Medicines and Healthcare Products Regulatory Agency- MHRA by another year, which means that it will come into effect in June 2024.

The legal director of UK legal firm Pinsent Masons, Louise Fullwood, went on to say that this further delay takes away the focus for manufacturers so as to get UKCA-ready, as it can continue to be kicked down the road with no possibility of what the eventual position is going to be.

A contributing element to the announced delay is that there are most likely to be a relatively small number of UK-approved bodies in order to carry out conformity assessments. Dekra had gone on to be appointed last month as just the third UK-approved body. More six organizations are going through the approval process, and the MHRA happens to be in discussions with numerous other potential candidates.

2024 is also going to witness the introduction of the Voluntary Scheme for Branded Medicines Pricing, Access, and Growth- VPAG system, which happens to be a replacement for the UKโ€™s previous VPAS system. This came about following prominent industry pushback on the proposed changes to the 2024 VPAS system, thereby resulting in industry-wide negotiations.

In the past, the changes proposed, which happened to be proposed by the Department for Health and Social Care, would have witnessed the imposition of a payback rate of 26.5% with the hope of maintaining the NHSโ€™ capacity to have branded medicines in the wake of COVID-19. But due to the industry pushback from groups like the British Pharmaceutical Industry- ABPI, a deal had gone on to be struck on 21 November 2023, thereby replacing the single payback rate set each year with two varied rates for newer as well as older medicines. It also goes on to change the annual allowed growth in sales of branded medicines from 2% this year rising to 4% by 2027. Medicines that are older and those that have not previously had a price decrease will pay a top-up rate of almost 25% along with a base rate of 10%.

Improving primary care in rural areas with telemedicine

Health professional shortage has remained a pressing problem throughout the US since 2020. However, rural areas are disproportionately affected: according to Statista, 65.5% of medical staff shortages in the primary care field are in rural areas, compared to 29.5% in urban and suburban ones. Despite joint efforts of healthcare organizations, software vendors, and the government to close this gap with the help of telemedicine solutions for primary care, rural patients remain medically underserved. The recent research conducted among the rural and urban Veterans Affairs beneficiaries showed the significant divide in telehealth usage.

Thus, to compensate for the medical staff deficit with telemedicine, we should consider the nuances of this technologyโ€™s implementation and usage, as applying the same adoption principles for rural and urban regions is counterproductive.

Telemedicine implementation and usage challenges in rural areas

Technical challenges

Internet bandwidth was listed as the number one barrier in telemedicine usage by rural patients. There are numerous factors contributing to low speed in many households: the necessity to attend school and work online for many people overburden the bandwidth of the rural Internet, which is already insufficient because of the rapidly aging infrastructure. At the same time, connectivity providers who strive to improve their services are rising prices, and new tariffs are often too high for the rural population. At the same time, video visits are among the most reimbursed and effective types of telecare. Consequently, healthcare providers prefer to hold video sessions while many people donโ€™t have the means to attend them.

Demographically determined challenges

The US Census Bureau found that the percentage of residents aged 65 and older is disproportionately higher in rural regions. Though smartphone and tablet usage has spread significantly among older people in the past ten years, their digital literacy still remains low.

That means patients who require doctorsโ€™ attention most often are the ones who donโ€™t have the skills to use telehealth technology. Additionally, many rural regions include a larger proportion of low-income households that canโ€™t afford smartphones and tablets with capabilities that support quality video conferencing.

Possible ways to increase the adoption and usage rates of telehealth in rural areas

Many of the above-mentioned issues canโ€™t be solved without changing the rural infrastructure and overall quality of life for rural populations. There are, however, a couple of actions that healthcare organizations can take right now to improve the situation.

  • Broadening the variability of patient communication and engagement channels

Active usage of audio consultations over the phone or live messaging can help those patients who canโ€™t communicate via video calls. Despite video format being the most effective type of telehealth services, healthcare providers should have fall-back options for situations when video fails.

For example, older patients can choose phone calls asย  a preferred form of communication.ย  Patients or their caregivers can also fill out some medical formsย  and send them to physicians to help assess patientsโ€™ condition better while cutting down the amount of videoconferencing time.

  • Establishing a point of care

Public libraries and coworking spaces have become the hub for people who donโ€™t have sufficient Internet access to work and study online. The same principle can be used to help people access virtual care. Setting up a point of care in the public facility with satisfactory connectivity and a trained medical practitioner who can assist patients with reaching their more experienced colleagues via telehealth would mitigate the problem of individual access to telehealth.

Patients with low Internet speed who require more in-depth care than what is possible to achieve via phone or text conversations still wouldnโ€™t have to travel far to see the doctor. At the same time, personnel in such centers wouldnโ€™t have to be fully trained primary physicians, as their required skills would be the ability to connect a patient to a licensed professional via the telehealth solution.

  • Providing more thorough education to patients and caretakers

Healthcare solution providers and medical professionals develop strategies to better inform rural patients about the telehealth options they have. Many patients might have no idea that it isnโ€™t always necessary to attend a video consultation, and they have other means of contacting their primary care provider.

Additionally, step-by-step instructions on how to properly set up and use each channel of communication must be available. Naturally, a support team should handle all technical questions from patients so the healthcare professionals donโ€™t have to.

  • Understanding a particular rural community and addressing issues

Each community has its own reasons for low telehealth adoption.ย  It is crucial for telehealth service providers to know their audience and build strategies to address the current challenges. Employing analytical solutions would be the best tactic. It allows healthcare and connectivity providers to gather data on the quality of Internet connection, as well as age and conditions of the patients, their income, and technological literacy in each rural region. Then they process this data and draw insights, which can be used to address the needs and limitations of each community.

In conclusion

Rural regions falling behind on telehealth adoption and usage is a systematic problem that requires action from multiple government and non-profit organizations, connectivity providers, software vendors, and other entities.

Updating telecommunication infrastructure, encouraging healthcare providers to take on more remote consultations, and fighting poverty in rural areas is essential to closing the gap between rural and urban communitiesโ€™ telehealth usage.

For now telehealth software providers and medical professionals can improve the situation by clearly understanding the rural patientsโ€™ needs and establishing more appropriate workflows for a particular patient group.

InterSystems Positioned as a Challenger in the 2023 Gartnerยฎ Magic Quadrantโ„ข for Cloud Database Management Systems

InterSystems was recognised for its completeness of vision and ability to execute

Sydney, Australia & Singapore, January 9, 2024ย โ€“ InterSystems, a leading provider in cutting-edge software for enterprise digital transformations, has been positioned as a Challenger in the Gartner Magic Quadrant for Cloud Database Management Systems (DBMS). This recognition is based on its completeness of vision and ability to execute execution. This marks the third time that InterSystems has been acknowledged in this report.

InterSystems IRIS data platform provides the connective tissue that transforms disparate data into a single, complete view, enabling better outcomes for customers with critical data needs within key markets such as healthcare, financial services and supply chain. InterSystems offers a unique smart data fabric approach, delivering high-performance multi-model and multi-workload database management, smart data services, interoperability and analytics capabilities.

InterSystems was evaluated by Gartner among 19 other vendors for managed cloud database systems. We believe that InterSystems positioning as a Challenger in the Magic Quadrant is testament to its ability to challenge the status quo, drive innovation, and provide unique solutions to the market.

Magic Quadrant reports are a culmination of rigorous, fact-based research in specific markets, providing a comprehensive view of the relative positions of providers in markets where growth is high and provider differentiation is distinct. Providers are positioned into four quadrants: Leaders, Challengers, Visionaries and Niche Players.

โ€œThe Challenger placement validates our commitment to innovation and focus on delivering value to our customers,โ€ said Scott Gnau, Head of Data Platforms, InterSystems. โ€œInterSystems inclusion as the sole Challenger in the Gartner Magic Quadrant demonstrates our success pushing the boundaries of whatโ€™s possible in cloud database management and helping organisations integrate, process and analyse their data in the cloud.โ€

A complimentary copy of the 2023 Magic Quadrant for Cloud Database Management Systems can be downloaded here: www.intersystems.com/mq

Translate ยป